XNAS
BON
Market cap7mUSD
Oct 07, Last price
1.16USD
1D
-0.85%
1Q
-2.52%
IPO
-95.12%
Name
Bon Natural Life Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Bon Natural Life Limited, accompanied by its various subsidiaries, focuses on the innovation, production, and worldwide distribution of active functional compounds sourced from natural plant extracts. Its operations span the People's Republic of China and international markets. The company's diverse product range includes components for personal care items, such as plant-derived aromatic compounds supplied to manufacturers of perfumes and fragrances. It also develops natural health products, featuring powdered beverages and biologically active food ingredients primarily intended for use as food additives, as well as a variety of nutritional supplements. These offerings are predominantly utilized by industrial clients in the functional food, personal care, cosmetic, and pharmaceutical sectors. Founded in 2006, Bon Natural Life Limited's main office is located in Grand Cayman, Cayman Islands.
Key people
Yongwei Hu
Chairman of the Board, Chief Executive Officer · since 2020
Wallace Lee
Chief Financial Officer · since 2023
Yingchun Xue
Chief Operating Officer · since 2024
Jianli Liu
Chief Technology Officer, Chief Scientist · since 2020
Wenjuan Chen
Chief Marketing Officer · since 2020
Jing Liu
Director · since 2024
Independent Director · since 2023
Christopher Constable
Independent Director · since 2021
Zhixiang Gao
Independent Director · since 2023
Jianjun Gao
Independent Director · since 2023
Independent Director · since 2021
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2025‑09 | 2024‑09 | 2023‑09 | 2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | 2018‑09 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||